A retrospective evaluation of activity of gemcitabine/platinum regimens in the treatment of recurrent ovarian cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2053-6844
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A retrospective evaluation of activity of gemcitabine/platinum regimens in the treatment of recurrent ovarian cancer ; volume:4 ; number:1 ; day:14 ; month:11 ; year:2017 ; pages:1-8 ; date:12.2017
Gynecologic oncology research and practice ; 4, Heft 1 (14.11.2017), 1-8, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Le, Tran N.
- Contributor
-
Harvey, Rachel E.
Kim, Christine K.
Brown, Jubilee
Coleman, Robert L.
Smith, Judith A.
SpringerLink (Online service)
- DOI
-
10.1186/s40661-017-0053-x
- URN
-
urn:nbn:de:1111-2017121913719
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Le, Tran N.
- Harvey, Rachel E.
- Kim, Christine K.
- Brown, Jubilee
- Coleman, Robert L.
- Smith, Judith A.
- SpringerLink (Online service)
Other Objects (12)
Gemcitabine in Recurrent Meningioma
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens: a systematic review and meta-analysis
Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada
Maintenance with Trabectedin in the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer
Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer
Economic evaluation of NALIRIFOX vs. nab-paclitaxel and gemcitabine regimens for first-line treatment of metastatic pancreatic ductal adenocarcinoma from U.S. perspective
Variants of ERCC5 and the outcome of platinum-based regimens in non-small cell lung cancer: a prospective cohort study
Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma
Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancer
Predictors of Compliance with Lithium and Carbamazepine Regimens in the Long-Term Treatment of Recurrent Mood and Related Psychotic Disorders
Gemcitabine in Recurrent Meningioma
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens: a systematic review and meta-analysis
Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada
Maintenance with Trabectedin in the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer
Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer
Economic evaluation of NALIRIFOX vs. nab-paclitaxel and gemcitabine regimens for first-line treatment of metastatic pancreatic ductal adenocarcinoma from U.S. perspective
Variants of ERCC5 and the outcome of platinum-based regimens in non-small cell lung cancer: a prospective cohort study
Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma
Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancer
Predictors of Compliance with Lithium and Carbamazepine Regimens in the Long-Term Treatment of Recurrent Mood and Related Psychotic Disorders
Gemcitabine in Recurrent Meningioma
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens: a systematic review and meta-analysis
Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada
Maintenance with Trabectedin in the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer
Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer
Economic evaluation of NALIRIFOX vs. nab-paclitaxel and gemcitabine regimens for first-line treatment of metastatic pancreatic ductal adenocarcinoma from U.S. perspective
Variants of ERCC5 and the outcome of platinum-based regimens in non-small cell lung cancer: a prospective cohort study
Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma
Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancer